New Age Alpha Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
New Age Alpha Advisors's VRTX Position: Q3 2026 in Review
New Age Alpha Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 8.6% in Q3 2026, selling an estimated $481K and leaving 9,987 shares worth $5.22M. The position accounts for 0.23% of the portfolio, ranked #95.
New Age Alpha Advisors first reported a position in VRTX in Q4 2024 and has held it in 8 quarters since. The position peaked at $6.99M in Q2 2025. 1,793 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- New Age Alpha Advisors held 9,987 shares of Vertex Pharmaceuticals worth $5.22M as of Q3 2026.
- New Age Alpha Advisors sold 940 Vertex Pharmaceuticals shares in Q3 2026, an estimated $481K.
- Vertex Pharmaceuticals made up 0.23% of New Age Alpha Advisors's portfolio in Q3 2026, its #95 holding.
- New Age Alpha Advisors first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
- New Age Alpha Advisors's Vertex Pharmaceuticals position peaked at $6.99M in Q2 2025.
- 1,793 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on New Age Alpha Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.